anthralin has been researched along with calcitriol in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (35.71) | 18.2507 |
2000's | 20 (47.62) | 29.6817 |
2010's | 7 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Clissold, SP; Murdoch, D | 1 |
Berth-Jones, J; Chu, AC; Dodd, WA; Ganpule, M; Griffiths, WA; Haydey, RP; Jurgensen, HJ; Klaber, MR; Murray, SJ; Rogers, S | 1 |
de Jong, EM; Ramaekers, FC; Troyanovski, SM; van de Kerkhof, PC; van Erp, PE; van Vlijmen, IM | 1 |
Lewis, HM | 1 |
Lowe, NJ; Simpson, KR | 1 |
Dobozy, A; Farkas, B; Kemény, L; Kenderessy, AS; Michel, G; Olasz, E; Ruzicka, T | 1 |
Berth-Jones, J | 1 |
Dutz, JP; Lui, H | 1 |
Altmeyer, P; Hermes, N; Hoffmann, K; Sander, P; Stücker, M | 1 |
Bos, JD; de Rie, MA; Out, TA | 1 |
Alatalo, E; Kontinen, J; Oikarinen, A; Röning, J; Savolainen, L | 1 |
Menday, AP; Poyner, TF; Wall, AR | 1 |
Federman, DG; Froelich, CW; Kirsner, RS | 1 |
Burgers, SA; van Vloten, WA | 1 |
Asadullah, K; Audring, H; Büttnerova, I; Döcke, WD; Prösch, S; Sterry, W; Volk, HD | 1 |
Lebwohl, M; Smith, KC | 1 |
Drainas, D; Monastirli, A; Papadimou, E; Tsambaos, D | 1 |
Menday, AP; Poyner, TF; Williams, ZV | 1 |
Hutchinson, PE; Marks, R; White, J | 1 |
Ashcroft, DM; Griffiths, CE; Li Wan Po, A; Williams, HC | 1 |
Ackermann, G; Eholzer, C; Karrer, S; Landthaler, M; Szeimies, RM | 1 |
Kowalzick, L | 1 |
Blomqvist, K; Davidsson, S; Molin, L; Mørk, C; Sigurgeirsson, B; Zachariae, H; Zachariae, R | 1 |
Franssen, ME; van de Kerkhof, PC | 1 |
Cowen, P | 1 |
Green, C; Hamberg, KJ; Hutchinson, PE; Jensen, JK; Kidson, P; Kragballe, K; Larsen, FG; Munro, CS; Tillman, DM; Van de Kerkhof, PC | 1 |
Bruner, CR; Feldman, SR; Fleischer, AB; Ventrapragada, M | 1 |
Bröcker, EB; Eggert, AA; Goebeler, M; Hofmann, UB | 1 |
Drainas, D; Stathopoulos, C; Tekos, A; Tsambaos, D | 1 |
Koo, J; Lee, E | 1 |
Damstra, R; de Rie, MA; de Vries, HJ; de Waard-van der Spek, FB; Haertlein, NG; Hol, CW; Kucharekova, M; Kunkeler, AC; Lijnen, RL; Oranje, AP; Swinkels, OQ; van de Kerkhof, PC; van der Valk, PG; van Hees, C; van Neer, P | 1 |
Ceović, R; Husar, K; Kostović, K; Lipozencić, J; Murat-Susić, S; Pasić, A; Skerlev, M | 1 |
Damstra, RJ; de Korte, J; de Rie, MA; de Waard-van der Spek, FB; Hol, CW; Kunkeler, AC; Lijnen, RL; Oranje, AP; Sprangers, MA; van de Kerkhof, PC; van der Valk, PG | 1 |
Laffitte, E; Thielen, AM | 1 |
de Jager, ME; de Jong, EM; Seyger, MM; van de Kerkhof, PC | 1 |
Bodendorf, MO; Grunewald, S; Kauer, F; Paasch, U; Rogalski, C; Schetschorke, M; Simon, JC | 1 |
Tidman, MJ | 1 |
Stein Gold, LF | 1 |
Andersen, F; Andersen, KE; Jeyabalan, J; Johannessen, H; Svendsen, MT | 1 |
15 review(s) available for anthralin and calcitriol
Article | Year |
---|---|
Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris.
Topics: Anthralin; Betamethasone; Calcitriol; Calcium; Cell Differentiation; Cell Division; Combined Modality Therapy; Humans; Psoriasis; Randomized Controlled Trials as Topic | 1992 |
Therapeutic progress. II: Treatment of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Emollients; Humans; Immunosuppressive Agents; Methotrexate; Phototherapy; Psoriasis; Retinoids; Tacrolimus; United Kingdom | 1994 |
Trends in topical psoriasis therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Humans; Psoriasis; Retinoids; Tars | 1994 |
Topical psoriasis therapy.
Topics: Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Calcitriol; Coal Tar; Dermatologic Agents; Humans; Keratolytic Agents; Nicotinic Acids; Patient Education as Topic; Psoriasis; Retinoids; Teaching Materials; Vitamin D | 1999 |
Topical antipsoriatics.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Calcitriol; Dermatologic Agents; Female; Humans; Male; Nicotinic Acids; Psoriasis; Sensitivity and Specificity | 2000 |
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Drug Therapy, Combination; Female; Humans; Male; Psoriasis; Ultraviolet Therapy | 2001 |
Psoriasis of the scalp. Diagnosis and management.
Topics: Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antifungal Agents; Calcitriol; Coal Tar; Diagnosis, Differential; Hair Preparations; Humans; Imidazoles; Keratolytic Agents; Patient Selection; Psoriasis; Salicylic Acid; Scalp Dermatoses; Severity of Illness Index | 2001 |
Management of psoriasis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agents; Emollients; Humans; Psoriasis; Quality of Life; Ultraviolet Therapy | 2001 |
A systematic review of adverse effects associated with topical treatments for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agents; Dihydroxycholecalciferols; Drug Therapy, Combination; Erythema; Humans; Nicotinic Acids; Pain; Pruritus; Psoriasis; Vitamin D | 2003 |
RNase P: a promising molecular target for the development of new drugs.
Topics: Aminoglycosides; Animals; Anthralin; Anti-Bacterial Agents; Calcitriol; Clinical Trials as Topic; Genetic Therapy; Humans; Peptidyl Transferases; Retinoids; Ribonuclease P | 2004 |
Treatment of childhood psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Calcitriol; Child; Cyclosporine; Humans; Methotrexate; Nicotinic Acids; Phototherapy; Psoriasis; Retinoids | 2006 |
[Topical treatments for psoriasis in 2009].
Topics: Administration, Cutaneous; Anthralin; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Emollients; Humans; Keratolytic Agents; Nicotinic Acids; Ointments; Psoriasis; PUVA Therapy; Quality of Life; Tacrolimus; Treatment Outcome; Vitamins | 2009 |
Efficacy and safety of treatments for childhood psoriasis: a systematic literature review.
Topics: Anthralin; Anti-Bacterial Agents; Calcineurin Inhibitors; Calcitriol; Child; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Psoriasis | 2010 |
Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
Topics: Administration, Cutaneous; Anthralin; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Nicotinic Acids; Patient Compliance; Pharmaceutical Vehicles; Practice Guidelines as Topic; Psoriasis; Quality of Life; Severity of Illness Index; Tacrolimus; Treatment Outcome; Vitamin D | 2016 |
Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Patient Compliance; Psoriasis | 2017 |
13 trial(s) available for anthralin and calcitriol
Article | Year |
---|---|
A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis.
Topics: Adult; Anthralin; Calcitriol; Calcium; Double-Blind Method; Female; Humans; Male; Observer Variation; Psoriasis; Severity of Illness Index | 1992 |
A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care Facilities; Anthralin; Anti-Inflammatory Agents; Body Surface Area; Calcitriol; Chronic Disease; Day Care, Medical; Dermatitis, Irritant; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythema; Humans; Middle Aged; Psoriasis; PUVA Therapy; Severity of Illness Index; Time Factors; Treatment Outcome | 1998 |
[Mometasone and calcipotriol optimize the initial therapeutic effect of dithranol in chronic persistent psoriasis].
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Calcitriol; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Mometasone Furoate; Pregnadienediols; Prospective Studies; Psoriasis; Recurrence | 1998 |
Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Balneology; Calcitriol; Combined Modality Therapy; Dermatologic Agents; Dose-Response Relationship, Radiation; Erythema; Humans; Lymphocyte Activation; Middle Aged; Psoriasis; Receptors, Interleukin-2; Severity of Illness Index; Solubility; T-Lymphocytes; Treatment Outcome; Ultraviolet Therapy | 1998 |
A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.
Topics: Activities of Daily Living; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Calcitriol; Dermatologic Agents; Female; Health Status; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Quality of Life; Self Concept; Treatment Outcome | 1998 |
Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Attitude; Calcitriol; Dermatologic Agents; Female; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Patients; Psoriasis | 2000 |
The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Calcitriol; Eczema; Emulsions; Erythema; Exanthema; Female; Humans; Male; Middle Aged; Ointments; Patient Dropouts; Patient Satisfaction; Prospective Studies; Pruritus; Psoriasis; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 2000 |
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Drug Therapy, Combination; Female; Humans; Male; Psoriasis; Ultraviolet Therapy | 2001 |
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Anthralin; Calcitriol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Probability; Psoriasis; Severity of Illness Index; Solutions; Treatment Outcome | 2002 |
Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Calcitriol; Calcium Channel Agonists; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome; Ultraviolet Therapy | 2003 |
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
Topics: Adult; Aged; Aged, 80 and over; Anthralin; Calcitriol; Day Care, Medical; Dermatologic Agents; Drug Administration Schedule; Humans; Middle Aged; Ointments; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome | 2006 |
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
Topics: Administration, Topical; Anthralin; Calcitriol; Day Care, Medical; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Netherlands; Ointments; Prospective Studies; Psoriasis; Quality of Life; Treatment Outcome | 2008 |
Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol.
Topics: Administration, Topical; Adult; Aged; Anthralin; Calcitriol; Combined Modality Therapy; Female; Humans; Lasers, Excimer; Male; Middle Aged; Psoriasis; Treatment Outcome | 2012 |
15 other study(ies) available for anthralin and calcitriol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Keratin 17: a useful marker in anti-psoriatic therapies.
Topics: Anthralin; Antibodies, Monoclonal; Biomarkers; Calcitriol; Frozen Sections; Gene Expression; Humans; Immunohistochemistry; Keratins; Psoriasis; Skin | 1991 |
The interleukin-8 receptor: a potential target for antipsoriatic therapy?
Topics: Anthralin; Calcitriol; Cells, Cultured; Cyclosporine; Flow Cytometry; HLA-DR Antigens; Humans; Interleukin-8; Keratinocytes; Neutrophils; Psoriasis; Receptors, Interleukin; Receptors, Interleukin-8A; Recombinant Proteins | 1994 |
Prescribing in psoriasis.
Topics: Anthralin; Calcitriol; Coal Tar; Cyclosporins; Humans; Methotrexate; Phototherapy; Psoriasis; Retinoids | 1994 |
Comparison of actual psoriasis surface area and the psoriasis area and severity index by the human eye and machine vision methods in following the treatment of psoriasis.
Topics: Acitretin; Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Calcitriol; Color; Dermatologic Agents; Eye; Female; Humans; Image Processing, Computer-Assisted; Keratolytic Agents; Male; Middle Aged; Photography; Psoriasis; PUVA Therapy; Quality Control; Reproducibility of Results; Severity of Illness Index; Skin; Tars | 1998 |
[Findings in children with psoriasis].
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Aspirin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Female; Genetic Predisposition to Disease; Humans; Male; Phototherapy; Psoriasis; Retrospective Studies; Tars; Treatment Outcome; Tretinoin | 1999 |
A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Antigens, Viral; Calcitriol; Case-Control Studies; Chi-Square Distribution; Cytomegalovirus; Dermatologic Agents; DNA, Viral; Humans; Leukocytes, Mononuclear; Phototherapy; Prevalence; Psoriasis; Skin; Statistics, Nonparametric; Tumor Necrosis Factor-alpha; Virus Latency | 1999 |
Additive inhibitory effect of calcipotriol and anthralin on ribonuclease P activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcitriol; Dictyostelium; Drug Synergism; Endoribonucleases; Enzyme Inhibitors; Humans; Ribonuclease P; RNA, Catalytic; Schizosaccharomyces | 2000 |
Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Calcitriol; Cost-Benefit Analysis; Decision Trees; Dermatologic Agents; Humans; Models, Economic; Psoriasis; Randomized Controlled Trials as Topic | 2000 |
Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Baths; Calcitriol; Dermatologic Agents; Female; Humans; Male; Methoxsalen; Middle Aged; Psoriasis; PUVA Therapy; Retrospective Studies; Treatment Outcome; Ultraviolet Therapy | 2001 |
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study.
Topics: Administration, Topical; Analysis of Variance; Anthralin; Anti-Inflammatory Agents; Calcitriol; Complementary Therapies; Cyclosporine; Dermatologic Agents; Europe; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Steroids; Surveys and Questionnaires | 2001 |
Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.
Topics: Acitretin; Anthralin; Calcitriol; Coal Tar; Combined Modality Therapy; Female; Humans; Keratolytic Agents; Male; Methotrexate; Middle Aged; Nicotinic Acids; Phototherapy; Psoriasis; Salicylic Acid; Severity of Illness Index; Time Factors; Ultraviolet Therapy | 2005 |
Childhood psoriasis: often favorable outcome.
Topics: Acitretin; Administration, Topical; Anthralin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Emollients; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Nicotinic Acids; Plant Extracts; Psoriasis; Receptors, Tumor Necrosis Factor; Salicylates; Steroids; Tars; Treatment Outcome; Ultraviolet Therapy | 2009 |
Improving outcomes in patients with psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Calcineurin Inhibitors; Calcitriol; Dermatologic Agents; Humans; Nicotinic Acids; Psoriasis; Quality of Life; Severity of Illness Index; Tars | 2013 |